Took less than 2 weeks.....
Mr. Allen Krantz reports
ADVANCED PROTEOME THERAPEUTICS CLOSES $900,000 PRIVATE PLACEMENT
Advanced Proteome Therapeutics Corp. has closed a non-brokered private placement financing as reported in Stockwatch Oct. 8, 2010, by the issuance of three million units at a purchase price of 30 cents per unit for gross proceeds of $900,000. Each unit consists of one common share in the capital of the company and one-half of a transferable share purchase warrant. Each whole warrant entitles the holder to purchase one additional common share in the capital of the company on or before Oct. 20, 2011, at a purchase price of 50 cents per share.
In connection with certain subscriptions of the private placement, the company paid a total of $67,275.00 cash in finders' fees to arm's-length parties, equal to 7 per cent of the gross subscription proceeds realized from the sale of units by the respective finder.
All securities issued by the company pursuant to the private placement are subject to a hold period of four months and one day, and cannot be resold until Feb. 22, 2011. Proceeds of the private placement will be used to advance the company's platform technologies and the testing of potential protein therapeutics and diagnostic imaging agents currently in development, as well as for general working capital.
We seek Safe Harbor.